The article details ASA’s new recommendations, published in Anesthesiology, for the appropriate management of neuromuscular monitoring and reversal of neuromuscular blockade drugs during general anesthesia. "The clinical recommendations for monitoring and reversing this process will help prevent residual neuromuscular blockade so patients benefit from complete recovery, which may decrease the length of stay in the post-acute care unit and postoperative lung complications," said ASA President Michael W. Champeau, M.D., FAAP, FASA. The piece was also picked up by the St. Louis Post-Dispatch, The Buffalo News (Buffalo, New York), Quad-City Times (Davenport, Iowa), and Wisconsin State Journal, among other outlets. (Login or subscription may be required.)
Curated by: Public Relations
Date of last update: January 11, 2023